CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 99 enrolled
Drug / intervention
Bupivacaine +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03653416
NCT03653416Phase 4Completed
CompareCT.gov

Comparison Between Ipack Block and Periarticular Infiltration in Total Knee Arthroplasty - a Randomized Control Trial

Icahn School of Medicine at Mount Sinai·interventional·Posted Aug 31, 2018·Updated Nov 3, 2020

In Brief

A Phase 4 clinical trial evaluating Ipack, Bupivacaine, and 1 other intervention for Osteo Arthritis Knee. Completed, enrolled 99 participants across 1 site.

Detailed Summary

Total knee arthroplasty(TKA) is an effective modality for the treatment of advanced osteoarthritis of the knee joint with excellent outcomes. With 719,000 cases being performed as of 2010, the incidence is expected to increase up to 3.48 million procedures annually by 2030.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteo Arthritis Knee
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedAug 31, 2018
Enrollment StartMar 1, 2018
Primary CompletionAug 1, 2019
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 7.8 years ago

Interventions

Ipackdevice

IPACK block - local anesthesia injected safely under ultrasound guidance in the interspace between the popliteal artery and capsule of the knee.

Bupivacainedrug

20 cc of bupivacaine(o.25%) injection

Peri Articular Infiltrationprocedure

Adductor Canal Catheter and Peri Articular Infiltration